Company News

Share this article:

GlaxoSmithKline will extend its strategic collaboration with Aspen, a pharmaceutical manufacturer, through the acquisition of a 16% shareholding in the company. In return, Aspen received the right to distribute GSK products in South Africa. Aspen is the largest generics manufacturer in the southern hemisphere, according to the company's website.

 

Sanofi-Aventis announced that it will acquire commercial rights to Oforta, a leukemia treatment manufactured by Antisoma, for $60 million, with further payments totaling $5 million. Antisoma is a biotech based in London and Boston.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.